USX:AVDR - Avedro Inc (USD 22.99) Avedro Inc
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist

Yahoo Finance
Note: This stock seems to be inactive

USD 22.99    +0.110 (+0.48%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

20 Nov 2019


20 Nov 2019

Day Change: 0.110 (0.48%)

52 Wk Range: 10.75 - 27.51

Day's Range: 22.18 - 23.04

Last Volume: 137,792

Current Yield: 0%

Projected Yield: 0%

Open: USD 22.91

27 Nov 2019

Metric AVDR S.Median
Beta 1.71 0.58
VaR 44.05 37.75
E.Shortfall 44.05 58.44
Liquidity 79.3K 15.67K


20 Nov 2019


Market Cap: 400M

Price Over Book: 9.072

Price Over Sales: NA

Return On Assets:

Return On Equity:

Price Over NAV: [Friends Only]


CEO: Reza Zadno

Sector: Health Technology

Industry: Medical Specialties

Useful Links


Avedro, Inc., an ophthalmic pharmaceutical and medical device company, develops and commercializes products to treat ophthalmic disorders and conditions, primarily associated with corneal weakness. The company's Avedro Corneal Remodeling platform comprises KXL and Mosaic systems, which deliver ultraviolet A or UVA light, and a suite of single-use riboflavin drug formulations. Its Avedro Corneal Remodeling platform treats corneal ectatic disorders and corrects refractive conditions; and KXL system in combination with Photrexa drug formulations used for the treatment of progressive keratoconus and corneal ectasia following refractive surgery. Avedro sells its products primarily to ophthalmologists, hospitals, and ambulatory surgery centers through a direct sales force in the United States, as well as through medical device distributors internationally. The company was formerly known as ThermalVision, Inc. and changed its name to Avedro, Inc. in October 2005. Avedro, Inc. was incorporated in 2002 and is headquartered in Waltham, Massachusetts.